(Total Views: 187)
Posted On: 09/02/2021 10:05:41 AM
Post# of 102809
$GTCH The company plans to use a non-invasive, photoplethysmographic (PPG) optical sensors. This optical sensor technology can track small variations in blood biological substances through the skin and with the use of AI algorithms determine blood sugar levels. GBT is now running feasibility simulations to assess accuracy and options. GBT is already using optical sensors in its qTerm device to measure heart rate, and blood oxygen levels and plans to use this light sensing technology to monitor glucose levels.
https://www.nasdaq.com/press-release/gbt-is-a...ce-2021-08
https://www.nasdaq.com/press-release/gbt-is-a...ce-2021-08
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
